Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsten Vandenberg

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Toxins|April 3, 2021
Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal TestingErin E Verity, Kathy Stewart, Kirsten Vandenberg, et al.
Frontiers in Immunology|December 3, 2025
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccinesJesse Bodle, David Burge, Gopal Gounder, et al.
Scientific Reports|May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticlesMeagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Frontiers in Immunology|April 10, 2023
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccinesJesse Bodle, Kirsten Vandenberg, Karen Laurie, et al.
Influenza and Other Respiratory Viruses|May 16, 2012
Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusionJesse Bodle, Erin E Verity, Chi Ong, et al.
Molecular Immunology|November 7, 2012
Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodiesSteve Rockman, Sarina Camuglia, Kirsten Vandenberg, et al.
The Journal of Infectious Diseases|June 12, 2014
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza virusesSinthujan Jegaskanda, Kirsten Vandenberg, Karen L Laurie, et al.
Ebiomedicine|April 15, 2017
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza InfectionSteven Rockman, Sue Lowther, Sarina Camuglia, et al.
Vaccine|October 16, 2012
Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza VaccineEugene Maraskovsky, Steve Rockman, Allison Dyson, et al.
Immunity|October 22, 2013
Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposureJing He, Louis M Tsai, Yew Ann Leong, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Toxins|April 3, 2021
Potency Testing of Venoms and Antivenoms in Embryonated Eggs: An Ethical Alternative to Animal TestingErin E Verity, Kathy Stewart, Kirsten Vandenberg, et al.
Frontiers in Immunology|December 3, 2025
Utilisation of monoclonal antibodies in the single radial immunodiffusion assay to determine potency and stability for seasonal and pandemic influenza vaccinesJesse Bodle, David Burge, Gopal Gounder, et al.
Scientific Reports|May 21, 2026
Using an RNA binding protein to detect mRNA on lipid nanoparticlesMeagan McMahon, Hareth Al-Wassiti, Kirsten Vandenberg, et al.
Frontiers in Immunology|April 10, 2023
An ELISA-based assay for determining haemagglutinin potency in egg, cell, or recombinant protein derived influenza vaccinesJesse Bodle, Kirsten Vandenberg, Karen Laurie, et al.
Influenza and Other Respiratory Viruses|May 16, 2012
Development of an enzyme-linked immunoassay for the quantitation of influenza haemagglutinin: an alternative method to single radial immunodiffusionJesse Bodle, Erin E Verity, Chi Ong, et al.
Molecular Immunology|November 7, 2012
Reverse engineering the antigenic architecture of the haemagglutinin from influenza H5N1 clade 1 and 2.2 viruses with fine epitope mapping using monoclonal antibodiesSteve Rockman, Sarina Camuglia, Kirsten Vandenberg, et al.
The Journal of Infectious Diseases|June 12, 2014
Cross-reactive influenza-specific antibody-dependent cellular cytotoxicity in intravenous immunoglobulin as a potential therapeutic against emerging influenza virusesSinthujan Jegaskanda, Kirsten Vandenberg, Karen L Laurie, et al.
Ebiomedicine|April 15, 2017
Intravenous Immunoglobulin Protects Against Severe Pandemic Influenza InfectionSteven Rockman, Sue Lowther, Sarina Camuglia, et al.
Vaccine|October 16, 2012
Scientific investigations into febrile reactions observed in the paediatric population following vaccination with a 2010 Southern Hemisphere Trivalent Influenza VaccineEugene Maraskovsky, Steve Rockman, Allison Dyson, et al.
Immunity|October 22, 2013
Circulating precursor CCR7(lo)PD-1(hi) CXCR5⁺ CD4⁺ T cells indicate Tfh cell activity and promote antibody responses upon antigen reexposureJing He, Louis M Tsai, Yew Ann Leong, et al.
Pageof 1